Veterinary Medicine Information website

Versifel CVR-T Lyophilisat und Suspension zur Herstellung einer Injektionssuspension für Katzen

Not authorised
  • Rabies virus, strain Flury LEP, Inactivated
  • Feline calicivirus, strain F9, Live
  • Felid herpesvirus 1, strain FVRm, Live
  • Feline panleucopenia virus, Live
Download as PDF

Product identification

Medicine name:
Versifel CVR-T Lyophilisat und Suspension zur Herstellung einer Injektionssuspension für Katzen
Active substance:
  • Rabies virus, strain Flury LEP, Inactivated
  • Feline calicivirus, strain F9, Live
  • Felid herpesvirus 1, strain FVRm, Live
  • Feline panleucopenia virus, Live
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain Flury LEP, Inactivated
    3.25
    international unit(s)
    /
    1.00
    millilitre(s)
  • Feline calicivirus, strain F9, Live
    316228.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
  • Felid herpesvirus 1, strain FVRm, Live
    100000.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
  • Feline panleucopenia virus, Live
    1000.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AH05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 64a/87
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 26/04/2022
Download